mRNA Vaccines & Therapeutics Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide mRNA Vaccines & Therapeutics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.6% during the forecast period.

    This report presents the market size and development trends by detailing the mRNA Vaccines & Therapeutics market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the mRNA Vaccines & Therapeutics market will be shown in this report. In short, this report will comprehensively reveal the characteristics of mRNA Vaccines & Therapeutics industry and will help you to build a panoramic view of the industrial development.

    mRNA Vaccines & Therapeutics Market, By Type:

    • Standardization Of Cancer Treatment MRNA Vaccine

    • Individualized Cancer Treatment MRNA Vaccine

    • Infectious Disease Treatment MRNA Vaccine

    • Infection Prevention MRNA Vaccine

    mRNA Vaccines & Therapeutics Market, By Application:

    • Hospital

    • Clinic

    • Others

    Some of the leading players are as follows:

    • GlaxoSmithKline Vaccines

    • Precision NanoSystems

    • Bayer

    • CRISPR Therapeutics

    • Moderna Therapeutics

    • MaxCyte

    • Boehringer Ingelheim

    • eTheRNA immunotherapies

    • BioNTech

    • RaNa Therapeutics

    • In-Cell-Art

    • Janssen

    • Kernal Biologics

    • AstraZeneca

    • PhaseRx

    • Novartis

    • CureVac

    • Ethris

    • Argos Therapeutics

    • Intellia Therapeutics

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of mRNA Vaccines & Therapeutics Market

    • 1.3 Market Segment by Type

      • 1.3.1 Standardization Of Cancer Treatment MRNA Vaccine

      • 1.3.2 Individualized Cancer Treatment MRNA Vaccine

      • 1.3.3 Infectious Disease Treatment MRNA Vaccine

      • 1.3.4 Infection Prevention MRNA Vaccine

    • 1.4 Market Segment by Application

      • 1.4.1 Hospital

      • 1.4.2 Clinic

      • 1.4.3 Others

    • 1.5 Market Segment by Regions

      • 1.5.1 North America mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of mRNA Vaccines & Therapeutics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of mRNA Vaccines & Therapeutics by Major Types

      • 3.4.1 Standardization Of Cancer Treatment MRNA Vaccine

      • 3.4.2 Individualized Cancer Treatment MRNA Vaccine

      • 3.4.3 Infectious Disease Treatment MRNA Vaccine

      • 3.4.4 Infection Prevention MRNA Vaccine

    4 Segmentation of mRNA Vaccines & Therapeutics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of mRNA Vaccines & Therapeutics by Major End-Users

      • 4.4.1 Hospital

      • 4.4.2 Clinic

      • 4.4.3 Others

    5 Market Analysis by Major Regions

    • 5.1 Global mRNA Vaccines & Therapeutics Production Analysis by Top Regions

    • 5.2 Global mRNA Vaccines & Therapeutics Consumption Analysis by Top Regions

    • 5.3 Global mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    6 Product Circulation of mRNA Vaccines & Therapeutics Market among Top Countries

    • 6.1 Top 5 Export Countries in mRNA Vaccines & Therapeutics Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in mRNA Vaccines & Therapeutics Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America mRNA Vaccines & Therapeutics Landscape Analysis

    • 7.1 North America mRNA Vaccines & Therapeutics Landscape Analysis by Top Countries

      • 7.1.1 United States mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 7.1.2 Canada mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 7.1.3 Mexico mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    8. Europe mRNA Vaccines & Therapeutics Landscape Analysis

    • 8.1 Europe mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 8.2 Europe mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    • 8.3 Europe mRNA Vaccines & Therapeutics Landscape Analysis by Top Countries

      • 8.3.1 Germany mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 8.3.2 UK mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 8.3.3 France mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 8.3.4 Italy mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 8.3.5 Spain mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 8.3.6 Belgium mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 8.3.7 Poland mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 8.3.8 Russia mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 8.3.9 Turkey mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 8.3.10 Netherlands mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 8.3.11 Portugal mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 8.3.12 Denmark mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 8.3.13 Finland mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 8.3.14 Iceland mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 8.3.15 Norway mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 8.3.16 Sweden mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific mRNA Vaccines & Therapeutics Landscape Analysis

    • 9.1 Asia Pacific mRNA Vaccines & Therapeutics Landscape Analysis by Top Countries

      • 9.1.1 China mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 9.1.2 Japan mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 9.1.4 India mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 9.1.5 ASEAN mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 9.1.6 South Korea mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    10 LAMEA mRNA Vaccines & Therapeutics Landscape Analysis

    • 10.1 LAMEA mRNA Vaccines & Therapeutics Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 10.1.2 Brazil mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 10.1.3 North Africa mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 10.1.4 South Africa mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 10.1.5 Argentina mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 GlaxoSmithKline Vaccines

      • 11.1.1 GlaxoSmithKline Vaccines Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Precision NanoSystems

      • 11.2.1 Precision NanoSystems Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Bayer

      • 11.3.1 Bayer Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 CRISPR Therapeutics

      • 11.4.1 CRISPR Therapeutics Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Moderna Therapeutics

      • 11.5.1 Moderna Therapeutics Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 MaxCyte

      • 11.6.1 MaxCyte Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Boehringer Ingelheim

      • 11.7.1 Boehringer Ingelheim Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 eTheRNA immunotherapies

      • 11.8.1 eTheRNA immunotherapies Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 BioNTech

      • 11.9.1 BioNTech Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 RaNa Therapeutics

      • 11.10.1 RaNa Therapeutics Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 In-Cell-Art

      • 11.11.1 In-Cell-Art Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Janssen

      • 11.12.1 Janssen Company Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Kernal Biologics

      • 11.13.1 Kernal Biologics Company Profile and Recent Development

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 AstraZeneca

      • 11.14.1 AstraZeneca Company Profile and Recent Development

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 PhaseRx

      • 11.15.1 PhaseRx Company Profile and Recent Development

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 Novartis

      • 11.16.1 Novartis Company Profile and Recent Development

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    • 11.17 CureVac

      • 11.17.1 CureVac Company Profile and Recent Development

      • 11.17.2 Market Performance

      • 11.17.3 Product and Service Introduction

    • 11.18 Ethris

      • 11.18.1 Ethris Company Profile and Recent Development

      • 11.18.2 Market Performance

      • 11.18.3 Product and Service Introduction

    • 11.19 Argos Therapeutics

      • 11.19.1 Argos Therapeutics Company Profile and Recent Development

      • 11.19.2 Market Performance

      • 11.19.3 Product and Service Introduction

    • 11.20 Intellia Therapeutics

      • 11.20.1 Intellia Therapeutics Company Profile and Recent Development

      • 11.20.2 Market Performance

      • 11.20.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 117 Figures and 194 Tables)

    • Figure Product Picture

    • Figure Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine

    • Figure Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine

    • Figure Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine

    • Figure Market Size and Growth Rate of Infection Prevention MRNA Vaccine

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Clinic

    • Figure Market Size and Growth Rate of Others

    • Figure North America mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure United States mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Canada mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Germany mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure UK mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure France mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Italy mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Spain mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Poland mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Russia mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure China mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Japan mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Australia mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure India mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure GCC mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of mRNA Vaccines & Therapeutics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of mRNA Vaccines & Therapeutics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of mRNA Vaccines & Therapeutics by Different Types from 2014 to 2026

    • Table Consumption Share of mRNA Vaccines & Therapeutics by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine

    • Figure Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine

    • Figure Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine

    • Figure Market Size and Growth Rate of Infection Prevention MRNA Vaccine

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of mRNA Vaccines & Therapeutics by Different End-Users from 2014 to 2026

    • Table Consumption Share of mRNA Vaccines & Therapeutics by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Clinic

    • Figure Market Size and Growth Rate of Others

    • Table Global mRNA Vaccines & Therapeutics Production by Major Regions

    • Table Global mRNA Vaccines & Therapeutics Production Share by Major Regions

    • Table Global mRNA Vaccines & Therapeutics Consumption by Major Regions

    • Table Global mRNA Vaccines & Therapeutics Consumption Share by Major Regions

    • Table North America mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table Europe mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table Asia Pacific mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table LAMEA mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America mRNA Vaccines & Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table North America mRNA Vaccines & Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure North America mRNA Vaccines & Therapeutics Consumption Share by Major Countries in 2014

    • Figure North America mRNA Vaccines & Therapeutics Consumption Share by Major Countries in 2018

    • Figure North America mRNA Vaccines & Therapeutics Consumption Share by Major Countries in 2026

    • Figure United States mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Europe mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table Europe mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Europe mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Europe mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Europe mRNA Vaccines & Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Europe mRNA Vaccines & Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure UK mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure France mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific mRNA Vaccines & Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific mRNA Vaccines & Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure China mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure India mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Vaccines

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline Vaccines

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline Vaccines

    • Table Product and Service Introduction of GlaxoSmithKline Vaccines

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Precision NanoSystems

    • Figure Sales and Growth Rate Analysis of Precision NanoSystems

    • Figure Revenue and Market Share Analysis of Precision NanoSystems

    • Table Product and Service Introduction of Precision NanoSystems

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CRISPR Therapeutics

    • Figure Sales and Growth Rate Analysis of CRISPR Therapeutics

    • Figure Revenue and Market Share Analysis of CRISPR Therapeutics

    • Table Product and Service Introduction of CRISPR Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Moderna Therapeutics

    • Figure Sales and Growth Rate Analysis of Moderna Therapeutics

    • Figure Revenue and Market Share Analysis of Moderna Therapeutics

    • Table Product and Service Introduction of Moderna Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MaxCyte

    • Figure Sales and Growth Rate Analysis of MaxCyte

    • Figure Revenue and Market Share Analysis of MaxCyte

    • Table Product and Service Introduction of MaxCyte

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Product and Service Introduction of Boehringer Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of eTheRNA immunotherapies

    • Figure Sales and Growth Rate Analysis of eTheRNA immunotherapies

    • Figure Revenue and Market Share Analysis of eTheRNA immunotherapies

    • Table Product and Service Introduction of eTheRNA immunotherapies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioNTech

    • Figure Sales and Growth Rate Analysis of BioNTech

    • Figure Revenue and Market Share Analysis of BioNTech

    • Table Product and Service Introduction of BioNTech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of RaNa Therapeutics

    • Figure Sales and Growth Rate Analysis of RaNa Therapeutics

    • Figure Revenue and Market Share Analysis of RaNa Therapeutics

    • Table Product and Service Introduction of RaNa Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of In-Cell-Art

    • Figure Sales and Growth Rate Analysis of In-Cell-Art

    • Figure Revenue and Market Share Analysis of In-Cell-Art

    • Table Product and Service Introduction of In-Cell-Art

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen

    • Figure Sales and Growth Rate Analysis of Janssen

    • Figure Revenue and Market Share Analysis of Janssen

    • Table Product and Service Introduction of Janssen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kernal Biologics

    • Figure Sales and Growth Rate Analysis of Kernal Biologics

    • Figure Revenue and Market Share Analysis of Kernal Biologics

    • Table Product and Service Introduction of Kernal Biologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PhaseRx

    • Figure Sales and Growth Rate Analysis of PhaseRx

    • Figure Revenue and Market Share Analysis of PhaseRx

    • Table Product and Service Introduction of PhaseRx

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CureVac

    • Figure Sales and Growth Rate Analysis of CureVac

    • Figure Revenue and Market Share Analysis of CureVac

    • Table Product and Service Introduction of CureVac

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ethris

    • Figure Sales and Growth Rate Analysis of Ethris

    • Figure Revenue and Market Share Analysis of Ethris

    • Table Product and Service Introduction of Ethris

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Argos Therapeutics

    • Figure Sales and Growth Rate Analysis of Argos Therapeutics

    • Figure Revenue and Market Share Analysis of Argos Therapeutics

    • Table Product and Service Introduction of Argos Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Intellia Therapeutics

    • Figure Sales and Growth Rate Analysis of Intellia Therapeutics

    • Figure Revenue and Market Share Analysis of Intellia Therapeutics

    • Table Product and Service Introduction of Intellia Therapeutics

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.